Philip Klein is the editor of National Review Online. Just 33 percent of Democrats said that they had a ‘very’ or ‘mostly’ favorable view of Israel, compared with 55 percent who said the ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...

Here, Belgium’s defence minister leans into boots on the ground, while Denmark’s EU minister opens up to more spending and joint EU debt. Belgium’s defence minister Theo Francken told the ...

Rwanda suspended development cooperation with Belgium for trying to “sabotage” its access to financing amid disagreements over its role in the conflict in eastern Democratic Republic of Congo.

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the ...

Pundit Stephen A. Smith again raised the possibility of a presidential run as a Democrat, blasting the party in the process and saying it has no obvious candidate to take on Republicans in the ...

The Foreign Office has issued a warning of "severe disruption" amid strike chaos in Belgium. Brits have been advised to check for possible delays after rail unions in Belgium announced plans to ...

The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent to trade at Rs 2,684 apiece on February 18, extending gains for the second straight session after releasing ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...

Stephen A. Smith has said the USA's 'joke' of a two-party system could drive him to run for president, with the ESPN personality saying 'something needs to be done.' Smith, who spoke exclusively ...

The Food and Drug Administration on Friday gave a green light to a new meningococcal vaccine from GSK. Dubbed Penmenvy, the “5-in-1” shot is approved for people aged 10 through 25 years old and ...